Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
Open Access
- 17 November 2020
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 14 (2) , 683-691
Abstract
Sjögren's syndrome (SS) is an autoimmune disease with no effective treatment options. Resolvin D1 (RvD1) belongs to a class of lipid‐based specialized pro‐resolving mediators (SPM’s) that showed efficacy in pre‐clinical models of SS. We developed a physiologically based pharmacokinetic (PBPK) model of RvD1 in mice and optimized the model using plasma and salivary gland pharmacokinetic studies performed in NOD/ ShiLtJ mice with SS‐like features. The predictive performance of the PBPK model was also evaluated with two external datasets from the literature reporting RvD1 pharmacokinetics. The PBPK model adequately captured the observed concentrations of RvD1 administered at different doses and in different species. The pharmacokinetics of RvD1 in virtual humans were predicted using the verified PBPK model at various doses (0.01 – 10 mg/kg). The first‐in‐human predictions of RvD1 will be useful for the clinical trial design and translation of RvD1 as an effective treatment strategy for SS.Keywords
Funding Information
- National Institutes of Health (R01DE027884)
This publication has 42 references indexed in Scilit:
- Understanding Resolvin Signaling Pathways to Improve Oral HealthInternational Journal of Molecular Sciences, 2013
- Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formationAmerican Journal of Physiology-Cell Physiology, 2012
- Sjogren′s syndrome complicated by non-Hodgkin′s lymphoma: Spectrum of lymphoid proliferations and associated hepatitis C virus infectionIndian Journal of Pathology and Microbiology, 2011
- Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United StatesHealth and Quality of Life Outcomes, 2009
- MR measurement of blood flow in the parotid gland without contrast medium: a functional study before and after gustatory stimulationNMR in Biomedicine, 2007
- New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseasesNature Clinical Practice Rheumatology, 2007
- Resolvin D1 and Its Aspirin-triggered 17R EpimerJournal of Biological Chemistry, 2007
- Epidemiology of connective tissue disordersRheumatology, 2006
- Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndromeJournal of Clinical Laboratory Analysis, 1993
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982